The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2026 | Importance of early detection and screening in lung cancer
James Reading, PhD, University College London, London, UK, discusses the importance of early detection and screening in improving outcomes for lung cancer patients, highlighting that screening programs such as CT screening can shift the presentation of the disease from late-stage to earlier stage, resulting in improved survival rates. Dr Reading notes that these programs can detect not only early cancers but also pre-invasive lesions, providing an opportunity for early detection and interception, and that understanding the mechanisms that convert pre-cancer into cancer can help identify targets for immunotherapies to prevent cancer development. This interview took place at the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
